Potent inhibition of bromodomain-containing BET family with ABBV-075 induces robust antitumor efficacy in preclinical models of breast cancer and exhibits in vitro synergy with doxorubicin

被引:0
|
作者
Faivre, Emily J.
Lin, Xiaoyu
Wilcox, Denise M.
Huang, Xiaoli
Sarthy, Aparna
Magoc, Terry
Albert, Daniel H.
Fang, Guowei
Rosenberg, Saul H.
McDaniel, Keith F.
Kati, Warren M.
Shen, Yu
机构
关键词
D O I
10.1158/1538-7445.AM2016-3077
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3077
引用
收藏
页数:3
相关论文
共 3 条
  • [1] The BET family bromodomain inhibitor ABBV-075 targets multiple pathogenesis factors in multiple myeloma and exhibits robust in vivo efficacies as a single agent and in combination with bortezomib
    Uziel, Tamar
    Lin, Xiaoyu
    Faivre, Emily
    Sarthy, Aparna
    Albert, Daniel H.
    Li, Leiming
    Wilcox, Denise
    Huang, Xiaoli
    Magoc, Terry
    Lam, Lloyd
    Elmore, Steven W.
    McDaniel, Keith
    Kati, Warren
    Shen, Yu
    CANCER RESEARCH, 2016, 76
  • [2] ABBV-075, a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo
    Faivre, Emily J.
    Wilcox, Denise M.
    Hessler, Paul
    Uziel, Tamar
    Tapang, Paul
    Magoc, Terry
    Albert, Daniel H.
    Fang, Guowei
    Rosenberg, Saul
    McDaniel, Keith
    McDaniel, Keith
    Kati, Warren
    Shen, Yu
    CANCER RESEARCH, 2016, 76
  • [3] Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia
    Zhang, Lu
    Cai, Tianyu
    Lin, Xiaoyu
    Huang, Xiaoli
    Bui, Mai H.
    Plotnik, Joshua P.
    Bellin, Richard J.
    Faivre, Emily J.
    Kuruvilla, Vinitha M.
    Lam, Lloyd T.
    Lu, Xin
    Zha, Zheng
    Feng, Weiguo
    Hessler, Paul
    Uziel, Tamar
    Zhang, Qi
    Cavazos, Antonio
    Han, Lina
    Ferguson, Debra C.
    Mehta, Gaurav
    Shanmugavelandy, Sriram S.
    Magoc, Terrance J.
    Rowe, Jenny
    Goodwin, Neal C.
    Dorritie, Kathleen A.
    Boyiadzis, Michael
    Albert, Daniel H.
    McDaniel, Keith F.
    Kati, Warren M.
    Konopleva, Marina
    Shen, Yu
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (10) : 1809 - 1819